US3895114A - Cyclic hydroxamic acids as antihypertensive agents - Google Patents
Cyclic hydroxamic acids as antihypertensive agents Download PDFInfo
- Publication number
- US3895114A US3895114A US333600A US33360073A US3895114A US 3895114 A US3895114 A US 3895114A US 333600 A US333600 A US 333600A US 33360073 A US33360073 A US 33360073A US 3895114 A US3895114 A US 3895114A
- Authority
- US
- United States
- Prior art keywords
- antihypertensive agents
- hydroxamic acids
- cyclic hydroxamic
- agents
- cyclic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
Definitions
- This invention relates to a method of treating hypertension using cyclic hydroxamic acids as the antihypertensive agents.
- Aspergillic acid and a number of its derivatives have been previously reported as anti-bacterial agents and some of the compounds have additionally been reported to possess antiinflammatory activity. It has now unexpectedly been found that the compounds are useful as antihypertensive agents.
- the antihypertensive activity of the compounds useful in the practice of this invention was first established in the spontaneously hypertensive rat using standard procedures.
- the compounds are effective as antihypertensive agents at dosages of from 60 to 200 mg./kg. of body weight daily.
- the compounds are administered to hypertensive patients, preferably by the oral route, in divided dosages, i.e., three to four times daily. They may also be co-administered with, for example, diuretics or tranquilizers in treating hypertension.
- the compounds can be administered alone, that is, as the sole component of a filled capsule, it is preferred to formulate the compound in various dosage forms for oral or parenteral administration such as tablets, syrups, sterile aqueous or non-aqueous suspension and the like.
- the oral dosage forms are prepared by methods well known in the art (as are the parenteral) and generally include a pharmaceutically acceptable carrier or diluent such as lactose, starch or sucrose along with lubricating agents such as magnesium stearate and flavoring and sweetening agents and the like.
- a method of reducing blood pressure in hypertensive patients by administering a therapeutically effective amount of a compound of the formula wherein R R and R each are hydrogen, alkyl, cycloalkyl or aryl.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Method of treating hypertension by administering to a hypertensive patient a therapeutically effective amount of a compound of the Formula
WHEREIN R1, R2, and R3 each are hydrogen, alkyl, cycloalkyl or aryl.
WHEREIN R1, R2, and R3 each are hydrogen, alkyl, cycloalkyl or aryl.
Description
United States Patent Jones et al.
[ CYCLIC HYDROXAMIC ACIDS AS ANTIHYPERTENSIVE AGENTS [75] Inventors: Peter Hadley Jones, Lake Forest;
Yvonne Connolly Martin, Waukegan, both of I11.
[73] Assignee: Abbott Laboratories, North Chicago, Ill.
22 Filed: Feb. 20, 1973 211 App]. No.: 333,600
Related US. Application Data [62] Division of Ser. No. 201,176, Nov. 22, 1971, Pat. No.
[52] US. Cl 424/263; 424/250 [51] Int. Cl A6lk 27/00 [58] Field of Search 424/250, 256, 263
[451 July 15,1975
[56] References Cited UNITED STATES PATENTS 2,666,054 1/1954 Safir 260/250 Primary Examiner-Stanley L Friedman Assistant ExaminerDaren M. Stephens Attorney, Agent, or Firm-Robert L. Niblack [57] ABSTRACT Method of treating hypertension by administering to a hypertensive patient a therapeutically effective amount of a compound of the Formula wherein R R and R each are hydrogen, alkyl, cycloalkyl or aryl.
1 Claim, No Drawings CYCLIC HYDROXAMIC ACIDS AS ANTII-IYPERTENSIVE AGENTS This is a division of application Ser. No. 201,176 filed Nov. 22, 1971 now U.S. Pat. No. 3,720,768.
DETAILED DESCRIPTION OF THE INVENTION This invention relates to a method of treating hypertension using cyclic hydroxamic acids as the antihypertensive agents.
Aspergillic acid and a number of its derivatives have been previously reported as anti-bacterial agents and some of the compounds have additionally been reported to possess antiinflammatory activity. It has now unexpectedly been found that the compounds are useful as antihypertensive agents.
The compounds useful in the practice of this invention are represented by the formula See, for example, Dunn et al., Pyrazine Derivatives XI Synthesis of Cyclic I-Iydroxamic Acids Related to As pergillic Acid J. Chem. Soc., 1949, 2707-l2; U.S. Pat. No. 2,666,054; Great Britain No. 1,238,958; France No. 2,022,146 and Great Britain No. 1,238,106.
The antihypertensive activity of the compounds useful in the practice of this invention was first established in the spontaneously hypertensive rat using standard procedures. The compounds are effective as antihypertensive agents at dosages of from 60 to 200 mg./kg. of body weight daily.
In the practice of this invention, the compounds are administered to hypertensive patients, preferably by the oral route, in divided dosages, i.e., three to four times daily. They may also be co-administered with, for example, diuretics or tranquilizers in treating hypertension.
While the compounds can be administered alone, that is, as the sole component of a filled capsule, it is preferred to formulate the compound in various dosage forms for oral or parenteral administration such as tablets, syrups, sterile aqueous or non-aqueous suspension and the like. The oral dosage forms are prepared by methods well known in the art (as are the parenteral) and generally include a pharmaceutically acceptable carrier or diluent such as lactose, starch or sucrose along with lubricating agents such as magnesium stearate and flavoring and sweetening agents and the like.
We claim:
1. A method of reducing blood pressure in hypertensive patients by administering a therapeutically effective amount of a compound of the formula wherein R R and R each are hydrogen, alkyl, cycloalkyl or aryl.
UNITED STATES PATENT AND TRADEMARK OFFICE CERTIFICATE OF CORRECTION PATENT NO. 3, 895, 114
DATED July 15, 1975 |NVENTOR(S) Peter Hadley Jones 6: Yvonne Connolly Martin It is certified that error appears in the above-identified patent and that said Letters Patent are hereby corrected as shown below:
On the front page in the abstract, please delete R2 N OH 2 0 N a w 0 O H and substitute 1 3 lfi S 6 IJH In Column 2, Claim 1, please delete 1U 3 1 R N OH R and substitute Signed and Scaled this ninth D a) of December I 9 75 '[SEAL] Attest.
RUTH C. MASON Arresting Officer C. MARSHALL DANN Commissioner ofPatenrs and Trademarks
Claims (1)
1. A METHOD OF REDUCING BLOOD PRESSURE IN HYPERTENSIVE PATIENTS BY ADMINISTERING A THERAPEUTICALLY EFFECTIVE AMOUNT OF A COMPOUND OF THE FORMULA
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US333600A US3895114A (en) | 1971-11-22 | 1973-02-20 | Cyclic hydroxamic acids as antihypertensive agents |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20117671A | 1971-11-22 | 1971-11-22 | |
| US333600A US3895114A (en) | 1971-11-22 | 1973-02-20 | Cyclic hydroxamic acids as antihypertensive agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3895114A true US3895114A (en) | 1975-07-15 |
Family
ID=26896471
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US333600A Expired - Lifetime US3895114A (en) | 1971-11-22 | 1973-02-20 | Cyclic hydroxamic acids as antihypertensive agents |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US3895114A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2666054A (en) * | 1949-11-23 | 1954-01-12 | American Cyanamid Co | Substituted pyrazines and method of preparing the same |
-
1973
- 1973-02-20 US US333600A patent/US3895114A/en not_active Expired - Lifetime
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2666054A (en) * | 1949-11-23 | 1954-01-12 | American Cyanamid Co | Substituted pyrazines and method of preparing the same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CZ286325B6 (en) | N-(endo-9-methyl-9-azabicyclo/3,3,1/non-3-yl)-1-methylindazole-3-carboxamide, use thereof for preparing a pharmaceutical preparation and the pharmaceutical preparation containing thereof | |
| HUT47217A (en) | Process for producing pharmaceutical compositions containing indol derivatives as active components | |
| AU601237B2 (en) | The use of paroxetine to treat pain | |
| US4234601A (en) | Analgesic potentiation | |
| US3624216A (en) | 8-substituted theophyllines as anti-inflammatory agents | |
| ES8104284A1 (en) | Substituted 3-amino-sydnonimines, process for their synthesis and pharmaceutical preparations containing them. | |
| US4181731A (en) | Novel therapeutic application of 4-carbamoyl-5-hydroxyimidazole | |
| US3624215A (en) | 8-substituted theophyllines as anti-anxiety agents | |
| US3895114A (en) | Cyclic hydroxamic acids as antihypertensive agents | |
| US3720768A (en) | Aspergillic acid as an antihypertensive agent | |
| JPS647045B2 (en) | ||
| EP0448029B1 (en) | Novel pharmaceutical uses of forskolin derivatives | |
| KR20020007188A (en) | Agent for treating parkinson's disease comprising astrocyte function-improving agent as active ingredient | |
| US3966978A (en) | 4-Biphenylacetic acid as an inhibitor of platelet aggregation | |
| GB1578128A (en) | Amidinopenicillanoyloxyalkyl amoxycillinates | |
| US3764679A (en) | Iodinin as an anti-hypertensive agent | |
| US6399650B2 (en) | Method for improving disturbancies of activities of daily living after stroke | |
| EP0218453A1 (en) | Improved antiinflammatory compositions and methods | |
| US4298611A (en) | Process for reducing blood pressure in animals | |
| EP0366033A2 (en) | Method of improving post-ischemic myocardial dysfunction using an ace inhibitor alone or in combination with a thrombolytic agent and combination | |
| EP0431277A1 (en) | Combination of a thromboxane A2 antagonist with a thrombolytic agent | |
| US3198705A (en) | Method of inducing hypotensive and ganglionic blocking activity | |
| EP0116238A1 (en) | Therapeutic compositions and their use in enhancing brain function | |
| US3777028A (en) | 5,5-dimethyl-10-hydroxy-8-(3-methyl-2-octyl)-2-(2-propynyl)-1,2,3,4-tetrahydro-5h-(1)-benzopyrano(3,4-d)pyridine as an anti-diarrheal agent | |
| US4225605A (en) | Ergolene or ergoline compounds for treating congestive heart failure |